Whole genome sequencing enables the identification of genetic variations, including single nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations by comparing with an internationally approved reference genome (for the species being studied). WGS plays a vital role in genomics by providing a comprehensive view of genetic makeup and helping researchers and clinicians better understand complex traits and diseases.

Applications of WGS include identifying genetic disorders, studying disease progression, and designing personalized medicine to enhance diagnosis and treatment. Further, WGS also facilitates the identification of new species, for example, by calculating the average nucleotide identity (ANI), where an ANI of <93% is considered species differentiation.

Types of whole genome sequencing techniques

Whole genome sequencing techniques include sequencing by synthesis, whole genome shotgun sequencing, bisulfite sequencing, low-pass sequencing, and single-cell sequencing. These methods provide comprehensive insights into genetic variations, DNA methylation, copy number variants, cellular heterogeneity, and tumor mechanisms to advance research in genomics, epigenetics, cancer, and precision medicine.

Sequencing by synthesis

This often-used approach sequences a DNA sample by attaching it to a solid support, producing single-stranded DNA. DNA polymerase is then used to synthesize the complimentary copy, where each incorporated nucleotide is noted. There are two techniques used:

• Short-read sequencing provides reads (around 150bp) and is cost-effective and accurate (>99.9%) sequencing reads. For example, bridge amplification generates copies of the target DNA using adaptors (with complementary sequences to oligonucleotides on a flow cell and unique identifiers). Double-stranded bridges of the DNA molecules are built by polymerase that is denatured to single-stranded, which is repeated many times. After cleaving and washing reverse strands, the forward strands are subjected to sequencing by synthesis using fluorescently labeled deoxyribonucleotide triphosphates.
• Long-read sequencing provides reads (10kb->1 Mb) and circumvents the use of PCR amplification. In this approach, the adaptors contain motor proteins driven by current where the sequence is identified by current changes in reference to a stretch of DNA bases of length “k” (kmer) or using single-molecule, real-time (SMRT) sequencing.

Whole genome shotgun sequencing

Whole genome shotgun sequencing involves fragmenting the genome into random small pieces, which are then sequenced and assembled using computational methods to reconstruct the entire DNA sequence.

Advantages and limitations

Whole genome shotgun sequencing provides comprehensive genomic coverage, enabling strain-level discrimination and detection of a wide range of microorganisms, including viruses, bacteria, and fungi. However, it has limitations such as high sequencing costs, potential host contamination, and reliance on reference genome databases, which can introduce biases, especially in complex or under-studied environments.

Whole genome bisulfite sequencing

Whole genome bisulfite sequencing (WGBS) aims to map DNA methylation at single-base resolution, enabling detailed analysis of key epigenetic modifications involved in gene regulation, genomic imprinting, and cell differentiation.

Applications in gene expression and epigenetics research

By providing high-resolution maps of important epigenetic modifications across the genome, WGBS helps researchers understand how methylation influences transcriptional silencing, genomic imprinting, and X-chromosome inactivation.

In gene expression studies, it allows the identification of differentially methylated regions (DMRs) that correlate with gene upregulation or repression, offering insights into disease mechanisms, such as cancer, where aberrant DNA methylation often plays a role.

Additionally, WGBS also aids in exploring epigenetic modifications in stem cell differentiation and development. For example, WGBS helped identify the dynamics of epigenetic remodeling in human induced pluripotent stem cells. DNA demethylation starts early in naive reprogramming, and epigenetic changes emerge midway through primed reprogramming.

Abcam offers DNA methylation kits designed to analyze key epigenetic modifications, including 5-mC, 5-hydroxymethylcytosine (5-hmC), and 5-formylcytosine (5-fC). For example, the colorimetric quantitative “Global DNA Methylation Assay Kit (5 Methyl Cytosine, Colorimetric) ab233486” kits help explore DNA methylation by measuring 5-mC with a sensitivity of 0.05% methylated DNA from 100 ng of input DNA, contributing to studies in gene regulation and disease.

This image is from an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted, which does not comply with these terms. Reference-Yong, WS., Hsu, FM. & Chen, PY. Profiling genome-wide DNA methylation. Epigenetics & Chromatin 9, 26 (2016). https://doi.org/10.1186/s13072-016-0075-3.

The figure shows how the reads from bisulfite sequencing and the reference genome are aligned. The DMRs are estimated after plotting methylation levels.

Abcam offers extensive kits and documents on DNA methylation and demethylation, exploring mechanisms like 5mC regulation. These resources include advanced techniques such as WGBS, DNA immunoprecipitation (DIP), and a comprehensive post-bisulfite DNA library preparation kit, which supports whole genome bisulfite sequencing, oxidative bisulfite sequencing, and reduced representation bisulfite sequencing.

Low-pass whole genome sequencing

Low-pass WGS (LP-WGS) is a high-throughput yet cost-effective method for detecting copy number variants in clinical settings. Low pass sequencing refers to an average depth of less than 1× coverage in the sequencing. Although point mutations cannot be assayed, multiplexing can lower the cost, and the design can be fitted as per the budget or logistics by adjusting the target coverage. LP-WGS has been described as a cost-effective and reliable tool to analyze copy number variants in clinical diagnostics.

LP-WGS combined with genotype imputation offers significant advantages over genotyping arrays for genome-wide association studies (GWAS) and polygenic risk score calculations. LP-WGS increases statistical power for GWAS and improves accuracy for polygenic risk prediction, particularly at coverages of approximately 0.5x. Additionally, it captures a broader range of genetic variation, including rare variants, without the ascertainment bias inherent in genotyping arrays.

Single-cell whole genome sequencing

Single-cell sequencing (SCS) technologies have advanced significantly, enabling detailed analyses of individual cell genomes, transcriptomes, and other multi-omics data. For example, the transcriptome is the portion of the genetic code transcribed into RNA, representing gene activity, offering more insights over just genome sequencing. These methods help reveal cellular heterogeneity, evolutionary relationships, and molecular mechanisms that traditional sequencing methods cannot detect.

Technology and methodology for single-cell sequencing

The methodology of SCS involves isolating individual cells, followed by amplification, sequencing, and bioinformatic analysis to obtain high-resolution data. Single cells can be obtained by techniques such as microdroplets (encapsulating individual cells in micro-level drops with a unique barcode), limited dilution (the suspension is passed through a moving pipette and liquid transfer machine), and flow cytometry-assisted sorting (FACS).

Recent developments such as single-cell combinatorial marker sequencing (SCI-seq), single-cell whole genome amplification (SCWGA), and single-cell chromatin organization and locus localization sequencing offer new ways to study genetic variations, chromatin states, and mutations at a lower cost.

Techniques like topographic single-cell sequencing (TSCS) and microwell-based single-cell RNA sequencing (microwell-seq) improve spatial accuracy and throughput. On the other hand, split pool ligation-based transcript sequencing (SPLit-seq) drastically reduces the cost of single-cell transcriptome sequencing.

Additionally, integrating CRISPR technologies with single-cell sequencing, such as CRISPR-based RNA sequencing, has enabled high-throughput functional analysis, expanding the scope of single-cell applications in biomedical research.

Applications in cancer research and precision medicine

SCS technologies have significantly advanced the study of tumor heterogeneity and its immune microenvironment. They offer valuable insights into cancer mechanisms and potential therapeutic targets across various cancers, including colorectal, breast, and brain tumors.

SCS in precision medicine enhances cancer genomics by enabling the analysis of gene expression, DNA variation, epigenetic state, and nuclear structure. This approach offers potential improvements in cancer diagnostics, targeted therapy, early detection, and non-invasive monitoring while transforming cancer research.

Whole genome sequencing process

WGS sequences the entire genome, including coding and noncoding regions, while whole exome sequencing (WES) focuses only on coding regions. While WGS offers better coverage and a more comprehensive view of the genome, it is more expensive and requires more storage. WGS covers up to 98% of the entire human genome, while WES covers 1–2% of the genome (almost 95% of the coding regions).

WGS can reach a sensitivity of 95% in identifying SNPs (around 14 reads average), while the coverage for WES is 20–40 × (yield is 25-35%; 49% in a consanguineous cohort). A study on six congenital asplenia patients showed that quality parameter distribution was more uniform for single-nucleotide variants (SNVs) and insertions/deletions (indels) in WGS vs. WES; 656 high-quality coding SNVs were covered by WGS that were missed in WES.

Steps in the whole genome sequencing process

• Sample preparation and DNA fragmentation

  • Sample preparation for WGS involves isolating high-quality DNA from cell lines and lysates from the organism of interest.
  • Mechanical or enzymatic methods are then used to fragment the DNA into smaller pieces to make sequencing more manageable. These fragments are used to construct sequencing libraries.

Abcam offers genomic DNA extraction kits for the rapid isolation of high-purity genomic DNA from blood leukocytes or cultured mammalian cells.

• Library construction and sequencing

  • Library construction involves preparing fragmented DNA by adding adaptors to the fragments, making them suitable for sequencing.
  • Various sequencing technologies are then used to read these DNA fragments, each offering unique advantages in read length, accuracy, and throughput.

• Data analysis and genome assembly

  • The data undergoes quality filtering to remove poor-quality sequences.
  • For reference-based analysis, sequences are aligned to a known genome. On the other hand, in de novo assembly, the genome is built from scratch without a reference.
  • Genome assembly involves piecing together the short reads into longer contigs, which are sequences that overlap in a manner to provide the sequence; the actual sequence can be derived by identifying the overlaps between sequence reads using specialized software to manage large datasets effectively.
  • The assembled genome is then annotated to identify genes, regulatory elements, and potential variations such as SNPs or indels, offering valuable insights into the organism's genetic characteristics.

Abcam offers high-sensitivity DNA library preparation kits designed to efficiently prepare DNA libraries from minimal sample amounts for next-generation sequencing applications.

Whole genome sequencing vs. whole exome sequencing

Benefits of whole genome sequencing

WGS delivers a complete and detailed map of an organism's genetic material, providing comprehensive insights into the genome. It enables the identification of all genetic variants, structural variations, and regulatory elements for comprehensive genomic analysis.

A study of Asiatic wild ass and its hybrids using WGS revealed significant genetic diversity and identified key genes, including the KIT ligand gene (KITLG), associated with coat color, meat quality, and immunity. These findings provided new insights into their phenotypic traits and evolutionary adaptations. In another study, WGS of SARS-CoV-2 isolates revealed that the third wave was mainly attributed to the Delta (B.1.617.2) variant; mapping to the Wuhan reference genome helped identify several point mutations.

WGS can help guide understanding the pathogenesis and designing treatment approaches and vaccines. For example, WGS helped understand the role of variant-specific immune evasion and waning protection to lower vaccine effectiveness.

Applications in diagnostics and personalized medicine

WGS plays a vital role in diagnostics and personalized medicine by enabling the precise identification of genetic disorders and detecting specific mutations associated with individual health conditions.  For example, WGS was used to identify mutations in clinically intractable rare diseases in individuals from 16 families, such as a copy number variation in 3p deletion syndrome and novel pathogenic variants IGF2/INS-IGF2 in mitochondrial disease and FBN3 in Klippel–Trenaunay–Weber syndrome. This capability supports the development of customized treatment strategies based on a patient's unique genetic profile.

Additionally, risk stratification of patients with inconclusive cytogenetic analysis results into risk groups with significantly different clinical outcomes was facilitated by WGS.

By comprehensively identifying pathogenic genetic variants, including those in noncoding regions often missed by traditional methods, such as conventional genetic testing like karyotype analysis, fluorescence in situ hybridization, X chromosome inactivation, polymerase chain reaction for triplet repeat expansion, and chromosomal microarray, WGS enhance diagnostic accuracy. It also allows for monitoring disease progression and mutation dynamics, facilitating improved target selection to optimize therapies and achieve better patient outcomes.

Moreover, WGS contributes to the discovery of novel disease-associated genes and helps clarify complex genotype-phenotype relationships, deepening our understanding of rare diseases.  For example, WGS was used to detect a novel BCR-ABL1 fusion gene in a rare case of chronic myeloid leukemia with breakpoints in the BCR intron 14 and the ABL1 intron 2, respectively. Further study helped guide personalized treatment in the patient, which improved the condition. Additionally, it supports large-scale population genomics research, tracking mutation patterns, assessing genetic diversity, and exploring evolutionary changes.

Advancements in evolutionary and population genetics

Advancements in evolutionary and population genetics are significantly enhanced by WGS, which provides comprehensive data on genetic variation across entire genomes. It enables researchers to trace lineage, identify genetic adaptations, and understand the mechanisms driving evolutionary changes within populations.

WGS facilitates the discovery of rare variants and complex genetic interactions. It offers deeper insights into population structure, migration patterns, and the evolutionary history of diverse species, broadening our understanding of genetic diversity and adaptation.

Challenges and limitations of whole genome sequencing

• Cost factors and accessibility: The cost of WGS has decreased dramatically from billions of dollars during the Human Genome Project. Despite this, affordability remains an issue for many researchers and institutions, especially in low-resource settings. For instance, a study reported that sequencing a human genome in 2006 cost between $20 million and $25 million. In contrast, a 2018 review found that the cost had dropped significantly, ranging from $1,906 to $24,810.
• Accessibility is further hindered by the need for specialized equipment, skilled personnel, and computational resources to process and analyze data. Ongoing innovation in sequencing technologies is expected to reduce sequencing costs and improve global access over time.
• Data volume and complexity in analysis: WGS generates vast amounts of data, requiring significant computational power and storage capacity for analysis. Interpreting this data involves identifying meaningful patterns and variations, which can be challenging due to an incomplete understanding of the genome's functional elements. The complexity of sequencing data often necessitates advanced bioinformatics tools, high-performance computational tools, and expertise, creating barriers for smaller research facilities.
• Ethical considerations and privacy concerns: WGS raises significant ethical concerns, particularly regarding the risk of privacy breaches due to the sensitive and personal nature of genomic data. The potential for misuse of genetic information, such as unauthorized access or discrimination based on genetic predispositions, poses a serious challenge.
  Ensuring informed consent is another significant issue, as participants must fully understand the implications of sharing their genome, including risks to family members' privacy.
  Additionally, the secondary use of genomic data for purposes beyond the original consent heightens ethical dilemmas. For example, public data release has two sides; when genetic susceptibility to a disease is revealed, it could lead to anxiety in the individual, stigmatization, and discrimination by denying employment or insurance. This underscores the need for strict protocols and transparency in research practices.

Current trends in whole genome sequencing technology

Emerging technologies are transforming genome analysis, while advances in sequencing technology improve accessibility. However, the societal impacts of WGS require addressing ethical, privacy, and equity challenges.

Emerging technologies and innovations

Advancements in sequencing technologies are driving genetic research and accessibility, enhancing genome analysis, disease understanding, and personalized medicine.

Artificial intelligence (AI) and machine learning (ML) in genome analysis

AI and ML are transforming genetics by enabling the analysis of vast genomic datasets to uncover patterns and relationships previously inaccessible. These technologies facilitate the identification of genetic variants, structural changes, and hereditary patterns associated with diseases, significantly advancing our understanding of genetic mechanisms.

Deep learning models have enhanced the precision of gene editing techniques like CRISPR and improved predictions of gene-disease associations. By integrating genetic data with phenotypic and environmental factors, AI is driving breakthroughs in personalized medicine and facilitating the study of complex genetic traits.

Explainable artificial intelligence (XAI) further enhances transparency by providing insights into model predictions, particularly in analyzing noncoding regulatory regions like enhancers. This approach aids in uncovering molecular principles underlying diseases such as cancer, fostering advancements in diagnosis and therapeutic strategies.

Increasing affordability and accessibility

Over the past two decades, the maturation of high-throughput short-read sequencing technology has significantly advanced genome studies, providing a foundational approach to nucleic acid analysis. Most recently, single-molecule, long-read sequencing has emerged as a powerful tool, addressing challenges in genome assembly, epigenome analysis, and transcriptome characterization.

With progress in accuracy and affordability, these technologies have expanded beyond whole genome assembly to applications like targeted sequencing, chromatin state measurement, and protein-DNA interaction analysis. This makes sequencing technologies increasingly accessible and practical for diverse biological and clinical applications.

Potential societal impacts of whole genome sequencing adoption

The adoption of WGS has the potential to revolutionize healthcare by enabling precision medicine and advancing research. However, it also raises concerns about privacy, data ownership, and accessibility, potentially exacerbating socioeconomic disparities. Addressing these impacts requires robust ethical frameworks, equitable access, and public engagement to ensure societal benefits are maximized while mitigating risks.

FAQs

What are the main applications of whole genome bisulfite sequencing in research?

Whole genome bisulfite sequencing is primarily used in research to analyze DNA methylation patterns at single-base resolution across entire genomes. It enables the study of epigenetic modifications and their role in gene regulation, development, and disease.

It is widely applied to investigate differential methylation in specific loci, cytosine –phosphate–guanine (CpG) islands, and repetitive elements, advancing our understanding of processes like cancer progression, stress responses, and genome-wide epigenetic changes.

How does low-pass whole genome sequencing compare to high-pass sequencing in terms of cost and accuracy?

Low-pass whole genome sequencing is less expensive and suitable for detecting large-scale genomic changes like structural variants, but the accuracy for fine-resolution analysis is compromised. In contrast, high-pass sequencing is costlier but provides greater accuracy, enabling detailed detection of single nucleotide variants and comprehensive genomic insights.

What advancements have been made in single-cell whole genome sequencing technology?

Advancements in single-cell whole genome sequencing technology include the ability to analyze individual microbial genotypes and functions, enabling detailed insights into genetic diversity and functional heterogeneity. Techniques like Microbe-seq now allow single-cell resolution, surpassing traditional methods by uncovering rare genetic variants and elucidating microbial roles in health and disease.